Lilly Sues Israel's Perrigo For Axiron Patent Infringements
This article was originally published in PharmAsia News
Executive Summary
Eli Lilly has filed a U.S. patent-infringement suit to block a generic of its Axiron testosterone drug by Perrigo Israel Pharmaceuticals.